Morgens Waterfall Vintiadis & Co’s Guardant Health GH Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Buy	+14,000	New	+$1.52M	1.6%	18

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's GH Position: Q2 2026 in Review

Morgens Waterfall Vintiadis & Co opened a new position in Guardant Health (GH) in Q2 2026: 14,000 shares worth $2.1M. The stake represents 1.6% of the portfolio and ranks #18 among its holdings.

597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Morgens Waterfall Vintiadis & Co held 14,000 shares of Guardant Health worth $2.1M as of Q2 2026.
Guardant Health was a new Morgens Waterfall Vintiadis & Co position in Q2 2026.
Guardant Health made up 1.6% of Morgens Waterfall Vintiadis & Co's portfolio in Q2 2026, its #18 holding.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2026, filed 14 Aug 2026.